
Sign up to save your podcasts
Or
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.
5
77 ratings
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.
1,043 Listeners
31 Listeners
275 Listeners
309 Listeners
340 Listeners
386 Listeners
121 Listeners
318 Listeners
195 Listeners
84 Listeners
88 Listeners
425 Listeners
144 Listeners
18 Listeners
70 Listeners